These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25620096)

  • 21. Activity of Dipeptidyl Peptidase-IV/CD26 and Aminopeptidase N/CD13 in Secretome of Mesenchymal Stem Cells after Treatment with LPS and PMA.
    Ramezani Ali Akbari K; Fathollahi A; Hashemi SM; Pouriran R; Yeganeh F
    Iran J Immunol; 2020 Mar; 17(1):41-51. PubMed ID: 32224540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of a targeted prodrug strategy of enhance oral absorption of poorly water-soluble compounds.
    Chan OH; Schmid HL; Stilgenbauer LA; Howson W; Horwell DC; Stewart BH
    Pharm Res; 1998 Jul; 15(7):1012-8. PubMed ID: 9688053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
    Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
    J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Research of oral prodrugs: opportunities and challenges].
    Cao F; Ping QN; Chen J
    Yao Xue Xue Bao; 2008 Apr; 43(4):343-9. PubMed ID: 18664193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Susceptibility of milk protein-derived peptides to dipeptidyl peptidase IV (DPP-IV) hydrolysis.
    Nongonierma AB; FitzGerald RJ
    Food Chem; 2014 Feb; 145():845-52. PubMed ID: 24128555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.
    Akinboye ES; Brennen WN; Rosen DM; Bakare O; Denmeade SR
    Prostate; 2016 Jun; 76(8):703-14. PubMed ID: 26835873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The significance of hypersialylation of dipeptidyl peptidase IV (CD26) in the inhibition of its activity by Tat and other cationic peptides. CD26: a subverted adhesion molecule for HIV peptide binding.
    Smith RE; Talhouk JW; Brown EE; Edgar SE
    AIDS Res Hum Retroviruses; 1998 Jul; 14(10):851-68. PubMed ID: 9671214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Prodrug Approach: A Successful Tool for Improving Drug Solubility.
    Jornada DH; dos Santos Fernandes GF; Chiba DE; de Melo TR; dos Santos JL; Chung MC
    Molecules; 2015 Dec; 21(1):42. PubMed ID: 26729077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of dipeptidyl peptidase-IV activity and/or structure homologs in human meningiomas.
    Stremenová J; Mares V; Lisá V; Hilser M; Krepela E; Vanicková Z; Syrucek M; Soula O; Sedo A
    Int J Oncol; 2010 Feb; 36(2):351-8. PubMed ID: 20043068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. (2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor.
    Tajima A; Yamamoto K; Kozakai A; Okumura-Kitajima L; Mita Y; Kitano K; Jingu S; Nakaike S
    Eur J Pharmacol; 2011 Mar; 655(1-3):99-107. PubMed ID: 21262219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-Substituted Prodrugs of Mebendazole Provide Improved Aqueous Solubility and Oral Bioavailability in Mice and Dogs.
    Zimmermann SC; Tichý T; Vávra J; Dash RP; Slusher CE; Gadiano AJ; Wu Y; Jančařík A; Tenora L; Monincová L; Prchalová E; Riggins GJ; Majer P; Slusher BS; Rais R
    J Med Chem; 2018 May; 61(9):3918-3929. PubMed ID: 29648826
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the Inhibition of Dipeptidyl Peptidase-4 (DDP-4) Enzyme Route Dependent and/or Driven by High Peak Concentration?- Seeking Answers with ZYDPLA1, a Novel Long Acting DPP-4 Inhibitor, in a Rodent Model.
    Patel H; Joharapurkar AA; Bahekar R; Patel P; Kshirsagar SG; Modi N; Ghoghari A; Patel VJ; Jain MR; Srinivas NR; Patel PR; Desai RC
    Drug Res (Stuttg); 2017 Apr; 67(4):223-227. PubMed ID: 28158894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS-induced model of colitis in mice.
    Baticic L; Detel D; Kucic N; Buljevic S; Pugel EP; Varljen J
    J Cell Biochem; 2011 Nov; 112(11):3322-33. PubMed ID: 21751235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dipeptidyl peptidase IV and its inhibitors: therapeutics for type 2 diabetes and what else?
    Juillerat-Jeanneret L
    J Med Chem; 2014 Mar; 57(6):2197-212. PubMed ID: 24099035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dipeptidyl peptidase activity of CD26 in serum and urine as a marker of cholestasis: experimental and clinical evidence.
    Perner F; Gyuris T; Rákóczy G; Sárváry E; Görög D; Szalay F; Kunos I; Szönyi L; Péterfy M; Takács L
    J Lab Clin Med; 1999 Jul; 134(1):56-67. PubMed ID: 10402060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of esters as prodrugs for oral delivery of beta-lactam antibiotics.
    Mizen L; Burton G
    Pharm Biotechnol; 1998; 11():345-65. PubMed ID: 9760687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of CD26-deficiency on dipeptidyl peptidase 8 and 9 expression profiles in a mouse model of Crohn's disease.
    Buljevic S; Detel D; Pugel EP; Varljen J
    J Cell Biochem; 2018 Aug; 119(8):6743-6755. PubMed ID: 29693275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Further characterization of DPP IV-beta, a novel cell surface expressed protein with dipeptidyl peptidase activity.
    Blanco J; Jacotot E; Callebaut C; Krust B; Hovanessian AG
    Adv Exp Med Biol; 1997; 421():193-9. PubMed ID: 9330697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human thymocyte dipeptidyl peptidase IV (CD26) activity is altered with stage of ontogeny.
    Ruiz P; Zacharievich N; Hao L; Viciana AL; Shenkin M
    Clin Immunol Immunopathol; 1998 Aug; 88(2):156-68. PubMed ID: 9714693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats.
    Choi JS; Shin SC
    Int J Pharm; 2005 Mar; 292(1-2):149-56. PubMed ID: 15725561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.